Lack of effect of sertraline on the pharmacokinetics of alprazolam.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Psychopharmacology

• Publication date

  2000-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00004714-200010000-00020PMID 11001249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine

  2005cited by this paper
• A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine

  2004cited by this paper
• Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.

  1997cited by this paper
• Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine.

  1996cited by this paper
• The emerging role of cytochrome P450 3A in psychopharmacology.

  1995cited by this paper
• Fluoxetine impairs clearance of alprazolam but not of clonazepam

  1992cited by this paper
• Gas chromatographic analysis of alprazolam in plasma: replicability, stability and specificity.

  1990cited by this paper

• PharmGKB summary: sertraline pathway, pharmacokinetics

  2019cites this paper
• Understanding the pharmacokinetics of anxiolytic drugs

  2013cites this paper
• Selective Serotonin Reuptake Inhibitors

  2012cites this paper
• Benzodiazepine metabolism: an analytical perspective.

  2008cites this paper
• The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

  2006cites this paper
• In vitro cytochrome P450 inhibition data and the prediction of drug‐drug interactions: Qualitative relationships, quantitative predictions, and the rank‐order approach

  2005cites this paper
• JPET #93229 1 THE UTILITY OF IN VITRO CYTOCHROME P450 INHIBITION DATA IN THE PREDICTION OF DRUG-DRUG INTERACTIONS

  2005cites this paper
• Lack of Pharmacologic Interaction Between Paroxetine and Alprazolam at Steady State in Healthy Volunteers

  2004cites this paper
• Comparative CYP3A4 Inhibitory Effects of Venlafaxine, Fluoxetine, Sertraline, and Nefazodone in Healthy Volunteers

  2004cites this paper
• Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon

  2003cites this paper
• Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.

  2002cites this paper
• Clinical Pharmacokinetics of Sertraline

  2002cites this paper